Mg-2.7Nd-0.2Zn-0.4Zr （mass fraction, %） alloy was designed for degradable biomedical material. The ingots of the alloy were solution treated and then hot extruded. The extruded rods were heat treated with aging treatment, solution treatment and solution＋aging treatment, respectively. Microstructures of the alloy were observed by optical microscopy （OM） and scanning electron microscopy （SEM）. Mechanical properties at room temperature were tested. In vitro degradation behavior of the alloy immersed in simulated body fluid was measured by hydrogen evolution and mass loss tests. The degradation morphologies of the alloy with and without degradation products were observed by SEM. The results show that the grains grow apparently after solution treatment. Solution treatment improves the elongation of as-extruded alloy significantly and decreases the strength, while aging treatment improves the strength and reduces the elongation of the alloy. The yield ratio is reduced by heat treatment. The in vitro degradation results of the alloy show that solution treatment on the as-extruded alloy results in a little higher degradation rate and aging treatment on the alloy can reduce degradation rate slightly.
